This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.
Patients aged 18 years or older
Confirmed acute ischemic stroke on imaging
Treated with both thrombolysis and thrombectomy
Clinical follow-up data available at 90 days (mRS score)
Primary hemorrhagic stroke
Early death or loss to follow-up without evaluation
Poor-quality imaging that cannot be analyzed